Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Using Imaris to rigorously track PET-defined sites of lung inflammation in <i>Mycobacterium tuberculosis</i>-exposed non-human primates.

American journal of diagnostic imaging·2026
Same author

The study of immunological markers in tuberculosis across animal models and its translation to human research.

Lab animal·2026
Same author

Mast cells promote pathology and susceptibility in tuberculosis.

eLife·2026
Same author

Targeting the lung innate pathways during tuberculosis can improve vaccine-induced protection via Th17 responses in diversity outbred mice.

mBio·2026
Same author

Therapeutic remodeling of the tuberculosis granuloma with 1-methyl-D-tryptophan enhances CD8<sup>+</sup> T cell-macrophage interactions.

bioRxiv : the preprint server for biology·2025
Same author

Concurrent TB and HIV therapies control TB reactivation during co-infection but not chronic immune activation.

Nature communications·2025

Related Experiment Video

Updated: Feb 17, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.3K

Toward Tuberculosis Vaccine Development: Recommendations for Nonhuman Primate Study Design.

Dominick J Laddy1, Aurelio Bonavia2, Willem A Hanekom3

  • 1Pre-Clinical Models & Biomarker Discovery, Aeras, Rockville, Maryland, USA.

Infection and Immunity
|December 6, 2017
PubMed
Summary

Developing new tuberculosis (TB) vaccines requires better preclinical data. This study advocates for using nonhuman primates and standardizing methods to improve TB vaccine development and reduce clinical trial costs.

Keywords:
nonhuman primatetuberculosisvaccines

More Related Videos

Use of the Invertebrate Galleria mellonella as an Infection Model to Study the Mycobacterium tuberculosis Complex
09:23

Use of the Invertebrate Galleria mellonella as an Infection Model to Study the Mycobacterium tuberculosis Complex

Published on: June 30, 2019

12.6K
Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

11.1K

Related Experiment Videos

Last Updated: Feb 17, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.3K
Use of the Invertebrate Galleria mellonella as an Infection Model to Study the Mycobacterium tuberculosis Complex
09:23

Use of the Invertebrate Galleria mellonella as an Infection Model to Study the Mycobacterium tuberculosis Complex

Published on: June 30, 2019

12.6K
Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

11.1K

Area of Science:

  • Immunology
  • Vaccinology
  • Primate Models

Background:

  • Clinical trials for novel tuberculosis (TB) vaccines are resource-intensive.
  • Limited global resources necessitate efficient TB vaccine development pathways.
  • Robust preclinical data is crucial for advancing candidate vaccines.

Purpose of the Study:

  • To provide a rationale for the essential role of nonhuman primates in TB vaccine preclinical research.
  • To offer guidance on standardizing experimental design and endpoints for TB vaccine development.
  • To facilitate the progression of promising TB vaccine candidates into clinical trials.

Main Methods:

  • Review and synthesis of existing literature on nonhuman primate models in TB research.
  • Proposal for standardized experimental protocols and outcome measures.
  • Analysis of resource allocation in TB vaccine development.

Main Results:

  • Nonhuman primates offer a valuable model for predicting TB vaccine efficacy in humans.
  • Standardization of study designs and endpoints can enhance data comparability and reliability.
  • Optimized preclinical evaluation can mitigate risks and costs associated with clinical trials.

Conclusions:

  • Nonhuman primate models are critical for robust preclinical evaluation of TB vaccines.
  • Standardized approaches in preclinical research are essential for accelerating TB vaccine development.
  • Improved preclinical data supports informed decision-making for advancing TB vaccine candidates, optimizing resource utilization.